Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy

International Journal of Urology

Volumn 21, Issue 6, 2014, Pages 572-577

  Sasaki, Hiroshi ^a   Kido, Masahito ^a   Miki, Kenta ^a   Kuruma, Hidetoshi ^a   Takahashi, Hiroyuki ^a   Aoki, Manabu ^a   Egawa, Shin ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Local recurrence; Prostate cancer; Salvage partial brachytherapy

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION RESPONSE; RADIOISOTOPE THERAPY; SALVAGE THERAPY; SEMINAL VESICLE; BRACHYTHERAPY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; TREATMENT FAILURE;

AGED; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 84901689781     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12373     Document Type: Article

References (21)

1. Saigal CS, Gore JL, Krupski TL etal. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 2007; 110: 1493-1500.
2. Nguyen PL, D'Amico AV, Lee AK etal. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 2007; 110: 1417-1428.
3. Beyer DC. Salvage brachytherapy after external-beam irradiation for prostate cancer. Oncology (Huntingt.) 2004; 18: 151-158.
4. Moman MR, van den Berg CA, Boeken Kruger AE etal. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int. J. Radiat. Oncol. Biol. Phys. 2010; 76: 741-746.
5. Pucar D, Hricak H, Shukla-Dave A etal. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int. J. Radiat. Oncol. Biol. Phys. 2007; 69: 62-69.
6. Hsu CC, Hsu H, Pickett B etal. Feasibility of MR Imaging/MR Spectroscopy-Planned Focal Partial Salvage Permanent Prostate Implant (PPI) for Localized Recurrence After Initial PPI for Prostate Cancer. Int. J. Radiat. Oncol. Biol. Phys. 2013; 85: 370-377.
7. Cellini N, Morganti AG, Mattiucci GC etal. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 595-599.
8. Hughes L, Waterman FM, Dicker AP. Salvage of suboptimal prostate seed implantation: reimplantation of underdosed region of prostate base. Brachytherapy 2005; 4: 163-170.
9. Miki K, Kiba T, Sasaki H etal. Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial. BMC Cancer 2010; 10: 572-578.
10. Roach M III, Hanks G, Thames H Jr etal. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 965-974.
11. Satoh T, Matsumoto K, Fujita T etal. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 2005; 66: 114-118.
12. Crook JM, Bahadur YA, Robertson SJ etal. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer 1997; 79: 81-89.
13. Stock RG, Cesaretti JA, Unger P, Stone N. Distant and local recurrence in patients with biochemical failure after prostate brachytherapy. Brachytherapy 2008; 7: 217-222.
14. Lee A, D'Amico A. Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy. J. Clin. Oncol. 2005; 23: 8192-8197.
15. Crook J, Gillan C, Yeung I etal. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2007; 69: 426-433.
16. Reed D, Wallner K, Merrick G etal. Isodose patterns in patients with inadequate prostate brachytherapy coverage. Int. J. Radiat. Oncol. Biol. Phys. 2003; 56: 1480-1487.
17. Rouviere O etal. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor - correlation with biopsy findings. Urology 2004; 63: 922-927.
18. Kim CK etal. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J. Magn. Reson. Imaging 2009; 29: 391-397.
19. Haider MA etal. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008; 70: 425-430.
20. Wallace T, Avital I, Stojadinovic A etal. Multi-parametric MRI-directed focal salvage permanent interstitial brachytherapy for locally recurrent adenocarcinoma of the prostate: a novel approach. J. Cancer 2013; 4: 146-151.
21. Sugimura K, Carrington BM, Quivey JM, Hricak H. Postirradiation changes in the pelvis: assessment with MR imaging. Radiology 1990; 175: 805-813.